Sign up to save your podcasts
Or
Share 330: How a Trump presidency could affect the FDA, the biotech industry, and its stocks
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
330: How a Trump presidency could affect the FDA, the biotech industry, and its stocks
To dig into how the election results could affect all things biopharma, we brought on three guests for this episode: Lizzy Lawrence, STAT’s FDA reporter, Baird analyst Brian Skorney, and longtime biotech executive Daphne Zohar.
View all episodes
By STAT
4.5
303303 ratings
To dig into how the election results could affect all things biopharma, we brought on three guests for this episode: Lizzy Lawrence, STAT’s FDA reporter, Baird analyst Brian Skorney, and longtime biotech executive Daphne Zohar.
More shows like The Readout Loud
View all
Planet Money
30,951 Listeners
a16z Podcast
1,019 Listeners
Odd Lots
1,780 Listeners
How I Built This with Guy Raz
30,243 Listeners
The Daily
111,155 Listeners
KFF Health News' 'What the Health?'
482 Listeners
The Long Run with Luke Timmerman
123 Listeners
Tradeoffs
385 Listeners
Biotech 2050 Podcast
60 Listeners
Business Of Biotech
87 Listeners
BioCentury This Week
30 Listeners
Raising Health
146 Listeners
Biotech Hangout
10 Listeners
Ground Truths
44 Listeners
Money Stuff: The Podcast
364 Listeners